Prevalence of metabolic syndrome (MS) in patients with diabetes mellitus type 1 (DM1);Prevalencia del síndrome metabólico (SM) en pacientes con diabetes mellitus de tipo 1 (DM1)

Gaceta Medica de Mexico

Volumn 148, Issue 2, 2012, Pages 137-143

  Hermosillo, Aldo Ferreira ^a   Ortega, Guadalupe Vargas ^a   Virla, Baldomero González ^a   Atri, Moisés Mercado ^a   Ayala, Mario Molina ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Double diabetes; Metabolic syndrome; Type 1 diabetes mellitus

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; HYPOALPHALIPOPROTEINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; NATIONAL HEALTH ORGANIZATION; OBESITY; PREVALENCE;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; PREVALENCE; YOUNG ADULT;

EID: 84863189002     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gillespie K. Type 1 diabetes: pathogenesis and prevention. CMAJ. 2006;175:165-70.
2. Wherret DK, Daneman D. Prevention of type 1 diabetes. Endocrinol Metab Clin North Am. 2009;38:777-90.
3. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and treatment of high cholesterol. JAMA. 2001;285:2486-97.
4. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
5. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735-52.
6. DeFronzo RA, Hendler R, Simonson D. Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes. 1982;31:795-801.
7. DeFronzo RA, Simonson D, Ferrannini E. Hepatic and peripheral insulin resistance: a common feature of type 2 (noninsulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1982; 23:313-9.
8. Teupe B, Bergis K. Epidemiological evidence for «double diabetes». Lancet. 1991;337:361-2.
9. Chillarón JJ, Goday A, Pedro-Botet J. Síndrome metabólico, diabetes mellitus tipo 1 y resistencia a la insulina. MedClin (Barc). 2008;130: 466-71.
10. Arai K, Yokoyama H, Okuguchi F, et al. Association between Body Mass Index and core components of Metabolic Syndrome in 1486 patients with type 1 Diabetes Mellitus in Japan (JDDT13). Endocr J. 2008;55:1025-32.
11. Rodrigues TC, Canani LH, Gross JL. Metabolic Syndrome, Insulin Resistance and Cardiovascular Disease in Type-1 Diabetes Mellitus. Arq Bras Cardiol. 2010;94:125-30.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
13. Meijer JW, Bosma E, Lefrandt J, et al. Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores. Diabetes Care. 2003;26:697-701.
14. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002;39:S1-266.
15. Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Proposed international clinic diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677-82.
16. Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care. 2006;29:2528-38.
17. Báez MS, Novik V, Alegría F, Cardemil F, Riveros R, Bofill L. Síndrome metabólico en un grupo de pacientes diabéticos tipo 1. ¿Una nueva variedad de diabetes? Rev Med Chile. 2009;137:888-93.
18. Chillarón JJ, Flores-Le-Roux JA, Goday A, et al. Metabolic Syndrome and Type-1 Diabetes Mellitus: Prevalence and Associated Factors. Rev Esp Cardiol. 2010;63:423-9.
19. Clausen TD, Mathiesen ER, Hansen T, et al. Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab. 2009;94:2464-70.
20. The Metascreen Writing Committee. The metabolic Syndrome is a risk indicator of microvascular and macrovascular complications in Diabetes. Diabetes Care. 2006;29:2701-7.
21. Pambianco G, Costacou T, Orchard TJ. The prediction of major outcomes of type 1 diabetes: a 12 year prospective evaluation of three separate definitions of the metabolic syndrome, and their components and estimated glucose disposal rate: the Pittsburg Epidemiology of Diabetes Complications Study experience. Diabetes Care. 2007;30: 1248-54.
22. Momesso DP, Bussade I, Lima GA, Fonseca LP, Russo LA, Kupfer R. Body composition, metabolic syndrome and insulin resistance in type 1 diabetes mellitus. Arq Bras Endocrinol Metabol. 2011;55:189-93.
23. Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: «double diabetes» in the Diabetes Control and Complications Trial. Diabetes Care. 2007;30:707-12.
24. Momesso DP, Bussade I, Epifanio MA, Schettino CD, Russo LA, Kupfer R. Increased epicardial adipose tissue in type 1 diabetes is associated with central obesity and metabolic syndrome. Diabetes Res Clin Pract. 2011;91:47-53.